Literature DB >> 19444306

From genes to function: the next challenge to understanding multiple sclerosis.

Lars Fugger1, Manuel A Friese, John I Bell.   

Abstract

Susceptibility to multiple sclerosis is jointly determined by genetic and environmental factors, and progress has been made in defining some of these genetic associations, as well as their possible interactions with the environment. However, definitive proof for the involvement of specific genetic determinants in the disease will only come from studies that examine their functional roles in disease pathogenesis. New and combined approaches are needed to analyse the complexity of gene regulation and the functional contribution of each genetic determinant to disease susceptibility or pathophysiology. These studies should proceed in parallel with the use of genetically defined human populations to explore how both genetic and environmental factors affect the function of the pathways in individuals with and without disease, and how these determine the inherited risk of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444306     DOI: 10.1038/nri2554

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  84 in total

1.  Development of a human adaptive immune system in cord blood cell-transplanted mice.

Authors:  Elisabetta Traggiai; Laurie Chicha; Luca Mazzucchelli; Lucio Bronz; Jean-Claude Piffaretti; Antonio Lanzavecchia; Markus G Manz
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

2.  The risk of relapses in multiple sclerosis during systemic infections.

Authors:  Jorge Correale; Marcela Fiol; Wendy Gilmore
Journal:  Neurology       Date:  2006-07-26       Impact factor: 9.910

Review 3.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

5.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Authors:  Frida Lundmark; Kristina Duvefelt; Ellen Iacobaeus; Ingrid Kockum; Erik Wallström; Mohsen Khademi; Annette Oturai; Lars P Ryder; Janna Saarela; Hanne F Harbo; Elisabeth G Celius; Hugh Salter; Tomas Olsson; Jan Hillert
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

6.  Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.

Authors:  Lisa M Maier; David E Anderson; Christopher A Severson; Clare Baecher-Allan; Brian Healy; David V Liu; K Dane Wittrup; Philip L De Jager; David A Hafler
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

7.  Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors:  Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

8.  Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Authors:  Sreeram V Ramagopalan; Narelle J Maugeri; Lahiru Handunnetthi; Matthew R Lincoln; Sarah-Michelle Orton; David A Dyment; Gabriele C Deluca; Blanca M Herrera; Michael J Chao; A Dessa Sadovnick; George C Ebers; Julian C Knight
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

9.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  33 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

3.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis.

Authors:  Mohit Raja Jain; Qing Li; Tong Liu; Joseph Rinaggio; Amit Ketkar; Vincent Tournier; Kiran Madura; Stella Elkabes; Hong Li
Journal:  J Proteome Res       Date:  2012-02-06       Impact factor: 4.466

Review 5.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

6.  Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands.

Authors:  Gijsbert P van Nierop; Rogier Q Hintzen; Georges M G M Verjans
Journal:  J Neurovirol       Date:  2014-03-27       Impact factor: 2.643

7.  Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population.

Authors:  Michele Mishto; Elena Bellavista; Claudia Ligorio; Kathrin Textoris-Taube; Aurelia Santoro; Mara Giordano; Sandra D'Alfonso; Florinda Listì; Benedetta Nacmias; Elena Cellini; Maurizio Leone; Luigi M E Grimaldi; Chiara Fenoglio; Federica Esposito; Filippo Martinelli-Boneschi; Daniela Galimberti; Elio Scarpini; Ulrike Seifert; Maria Pia Amato; Calogero Caruso; Maria P Foschini; Peter M Kloetzel; Claudio Franceschi
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

Authors:  Dan Yang; Wei-Zhi Wang; Xue-Mei Zhang; Hui Yue; Bing Li; Lin Lin; Jin Fu
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

9.  Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis.

Authors:  Irene Guzmán-Soto; Eva Salinas; Irma Hernández-Jasso; J Luis Quintanar
Journal:  Neurochem Res       Date:  2012-07-26       Impact factor: 3.996

10.  Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.

Authors:  Nikolaos Paschalidis; Asif J Iqbal; Francesco Maione; Elisabeth G Wood; Mauro Perretti; Rod J Flower; Fulvio D'Acquisto
Journal:  J Neuroinflammation       Date:  2009-11-13       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.